© 2019 by Access for Life. Proudly created with Wix.com

  • LinkedIn Basic Black
  • Twitter Basic Black

News and Events

Mar 2018: Selected participant at the 1st China (Ningbo) Global Experts Summit (CGES) http://www.ocstab.net/index.php/en/activities-news/activity-details/the1st-china-ningbo-global-experts-summit-cges

Nov. 2017: Selected participant in the Global Startup Program Asia + in Taipei, Taiwan.  http://www.garageplus.asia/en/startups

Mission Statement: "We believe that entrepreneurs are mission-driven individuals who take actions to realize their dreams and bring a better life to the society through innovation."

May 2017: Mixiii Biomed 2017 conference, table in the Start-Up pavilion.

April 2017: Successful completion of 9 month vascularized tissue in-growth tissue study in rodents.  Study reports by expert histopathologist, Dr. Abraham Nyska, DVM, Dipl. ECVP, Fellow IATP. Slides prepared by Alizee Pathology, Thurmont, MD. 

Nov 2016: Access for Life named a Silver Award Winner of MassChallenge 2016.

Watch: https://www.youtube.com/watch?v=C9_fo75JnXk 

July 2016: Next stage of animal trials commenced at the GLPigs CRO, Assaf Harofeh Medical Center, Rishon Lezion, Israel.

May 2016: Won a place in the MassChallenge Accelerator Program in Jerusalem.

May 2016: Participated at the BioMed Conference Startup Area, Tel Aviv. 

April  2016: Won a EU Horizon 2020 Phase 1 SME Grant. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 728915.

Jan. 2016:  Pharmes Innovations Limited investment received, which will be used to fund the animal trials. As a result, David Grey has joined the Board of Directors.

 

Dec. 2015: Initial round of the large animal trials, pilot stage,  completed at the GLPigs CRO at Assaf Harofeh Medical Center, Tzrifin, Israel.

 

May 2015: Our CEO, Philip Libman, presented at the Israel Advanced Technology Institute’s Biomed 2015 Conference in Tel Aviv. 

Picture below from Biomed 2017 conference. From left: Dr. Yehuda Zicherman, Eyal Teichman, Philip Libman